IPO - SANGAMO THERAPEUTICS, INC

Form Type: 8-K

Filing Date: 2025-05-13

Corporate Action: Ipo

Type: New

Accession Number: 000114036125018697

Filing Summary: On May 12, 2025, Sangamo Therapeutics, Inc. entered into an underwriting agreement with Cantor Fitzgerald & Co. for the issuance and sale of 12,235,000 shares of common stock and pre-funded warrants to purchase 34,398,393 shares of common stock. The Offering also includes purchase warrants for an additional 46,633,393 shares. The combined offering price for the common stock is $0.50 and for the pre-funded warrants, it is $0.49. The total gross proceeds expected from the Offering are approximately $23.0 million before deductions. The Offering is set to close on May 14, 2025, subject to customary closing conditions. The document also outlines the terms of the securities, including exercise prices and limitations on ownership percentages for warrant holders. Forward-looking statements indicate that actual results may vary significantly from these expectations based on various factors.